Properties of Cardiac Myosin with Cardiomyopathic Mutations in Essential Light Chains

Biochemistry (Mosc). 2022 Nov;87(11):1260-1267. doi: 10.1134/S0006297922110050.

Abstract

The effects of cardiomyopathic mutations E56G, M149V, and E177G in the MYL3 gene encoding essential light chain of human ventricular myosin (ELCv), on the functional properties of cardiac myosin and its isolated head (myosin subfragment 1, S1) were investigated. Only the M149V mutation upregulated the actin-activated ATPase activity of S1. All mutations significantly increased the Ca2+-sensitivity of the sliding velocity of thin filaments on the surface with immobilized myosin in the in vitro motility assay, while mutations E56G and M149V (but not E177G) reduced the sliding velocity of regulated thin filaments and F-actin filaments almost twice. Therefore, despite the fact that all studied mutations in ELCv are involved in the development of hypertrophic cardiomyopathy, the mechanisms of their influence on the actin-myosin interaction are different.

Keywords: cardiac muscle; cardiomyopathic mutations; essential light chains; molecular mechanism of muscle contraction; myosin.

MeSH terms

  • Actin Cytoskeleton / metabolism
  • Actins / genetics
  • Actins / metabolism
  • Cardiac Myosins* / genetics
  • Cardiac Myosins* / metabolism
  • Humans
  • Mutation
  • Myosin Light Chains / genetics
  • Myosin Light Chains / metabolism
  • Myosins* / genetics
  • Myosins* / metabolism

Substances

  • Cardiac Myosins
  • Myosins
  • Actins
  • Myosin Light Chains